Release Date: 28/08/19 18:51 Summary: Windlab Initiates Strategic Review Price Sensitive: Yes Download Document 143.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%